Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY® Endovascular Robotic Surgical System. "We are very excited to have a hospital of the caliber of Baptist Hospital of Miami performing clinical cases. It is very encouraging to see the progress of our clinical study, as within a couple of weeks we now have two sites actively enrolling patients," commented Harel Gadot, CEO, President and Chairman of Microbot Medical. Baptist Hospital of Miami is ...